• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰筛查实验室类型对基于人群的宫颈病变发生率的影响。

Effect of type of screening laboratory on population-based occurrence of cervical lesions in Finland.

作者信息

Nieminen Pekka, Hakama Matti, Tarkkanen Jussi, Anttila Ahti

机构信息

Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland.

出版信息

Int J Cancer. 2002 Jun 10;99(5):732-6. doi: 10.1002/ijc.10396.

DOI:10.1002/ijc.10396
PMID:12115508
Abstract

The incidence of cervical cancer decreased in Finland over a 30-year period because of an effective screening program, but in the beginning of the 1990s it began to increase. Reasons for such an increase are variable: changes in sexual habits, shortcomings in attendance for screening and possibly variation in laboratory quality. We evaluated the impact of 3 laboratories in the greater Helsinki area on screening performance and on the incidence of invasive cervical cancer and preinvasive cervical lesions in the target population. We studied time trends, geographic differences in attendance and detection rates from screening and the incidence of invasive cancer in the greater Helsinki area (population about 1 million) during the 1990s, when screening was reorganized from the Cancer Society of Finland laboratory to the municipal one (Helsinki) and to a private laboratory (Espoo), while in Vantaa screening remained with the same Cancer Society laboratory. The attendance rate for screening increased during the study period in all 3 cities. The numbers of cytologically suspected and histologically confirmed precancerous lesions found, including severe lesions, decreased significantly with the change of laboratory in Espoo; but in Helsinki and Vantaa, they increased. The overall incidence of invasive cervical cancer increased in all cities in the age groups screened but mostly in Espoo. The rather rapid changes and variation in trends in the number of screening findings cannot be explained by changes in etiologic factors or attendance. They may be related more to the quality of the laboratory performance and perhaps to the criteria used in cytology and colposcopy. A well-organized auditing system is proposed to maintain high quality in screening.

摘要

由于有效的筛查计划,芬兰宫颈癌的发病率在30年期间有所下降,但在20世纪90年代初又开始上升。这种上升的原因多种多样:性行为习惯的改变、筛查参与率的不足以及可能的实验室质量差异。我们评估了大赫尔辛基地区3家实验室对筛查效果以及目标人群中浸润性宫颈癌和宫颈上皮内瘤变发病率的影响。我们研究了20世纪90年代大赫尔辛基地区(人口约100万)的时间趋势、筛查参与率和检出率的地理差异以及浸润性癌症的发病率,在此期间筛查从芬兰癌症协会实验室重新组织到赫尔辛基市立实验室和一家私立实验室(埃斯波),而万塔的筛查仍由同一家癌症协会实验室负责。在研究期间,所有3个城市的筛查参与率都有所上升。随着埃斯波实验室的更换,包括严重病变在内的细胞学可疑和组织学确诊的癌前病变数量显著减少;但在赫尔辛基和万塔,这些病变数量增加了。在所有接受筛查的年龄组中,浸润性宫颈癌的总体发病率在所有城市都有所上升,但在埃斯波上升幅度最大。筛查结果数量趋势的相当迅速的变化和差异无法用病因因素或参与率的变化来解释。它们可能更多地与实验室检测质量有关,也许还与细胞学和阴道镜检查所采用的标准有关。建议建立一个组织完善的审计系统以维持筛查的高质量。

相似文献

1
Effect of type of screening laboratory on population-based occurrence of cervical lesions in Finland.芬兰筛查实验室类型对基于人群的宫颈病变发生率的影响。
Int J Cancer. 2002 Jun 10;99(5):732-6. doi: 10.1002/ijc.10396.
2
Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.芬兰神经网络辅助宫颈癌筛查的前瞻性随机公共卫生试验:第一年的结果
Int J Cancer. 2003 Jan 20;103(3):422-6. doi: 10.1002/ijc.10839.
3
[Differences in cervical cancer mass screening results in Greater-Helsinki area].
Duodecim. 2000;116(22):2489-96.
4
Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland.筛查细胞学检查呈阳性后发生宫颈癌的风险:芬兰的随访研究
Acta Obstet Gynecol Scand. 2000 Jul;79(7):576-9.
5
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.芬兰和荷兰的宫颈癌大规模筛查计划及趋势
Int J Cancer. 2008 Apr 15;122(8):1854-8. doi: 10.1002/ijc.23276.
6
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.1963年至1995年芬兰有组织筛查对宫颈癌发病率和死亡率的影响:近期宫颈癌发病率上升
Int J Cancer. 1999 Sep 24;83(1):59-65. doi: 10.1002/(sici)1097-0215(19990924)83:1<59::aid-ijc12>3.0.co;2-n.
7
Quality improvement project in cervical cancer screening: practical measures for monitoring laboratory performance.宫颈癌筛查质量改进项目:监测实验室性能的实用措施
Acta Obstet Gynecol Scand. 2003 Jan;82(1):82-8. doi: 10.1034/j.1600-0412.2003.820115.x.
8
Low proportion of false-negative smears in the Finnish program for cervical cancer screening.芬兰宫颈癌筛查项目中假阴性涂片的比例较低。
Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):381-7. doi: 10.1158/1055-9965.EPI-09-1038.
9
Significant variation in performance does not reflect the effectiveness of the cervical cancer screening programme in Finland.筛查效果的显著差异并不能反映芬兰宫颈癌筛查项目的有效性。
Eur J Cancer. 2007 Jan;43(1):169-74. doi: 10.1016/j.ejca.2006.08.026. Epub 2006 Oct 16.
10
Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland.自我采样与提醒信:对芬兰宫颈癌筛查参与率和覆盖率的影响。
Int J Cancer. 2011 Jun 1;128(11):2681-7. doi: 10.1002/ijc.25581. Epub 2010 Jul 28.

引用本文的文献

1
A comparison of the effects of electronic reminders and group bonuses on the recording of diagnoses in primary care: a longitudinal follow-up study.电子提醒和团体奖金对初级保健中诊断记录的影响比较:一项纵向随访研究。
BMC Res Notes. 2017 Dec 6;10(1):700. doi: 10.1186/s13104-017-3054-2.